{Reference Type}: Journal Article
{Title}: Orphan peptide and G protein-coupled receptor signalling in alcohol use disorder.
{Author}: Anversa RG;Maddern XJ;Lawrence AJ;Walker LC;
{Journal}: Br J Pharmacol
{Volume}: 181
{Issue}: 5
{Year}: 2024 03 10
{Factor}: 9.473
{DOI}: 10.1111/bph.16301
{Abstract}: Neuropeptides and G protein-coupled receptors (GPCRs) have long been, and continue to be, one of the most popular target classes for drug discovery in CNS disorders, including alcohol use disorder (AUD). Yet, orphaned neuropeptide systems and receptors (oGPCR), which have no known cognate receptor or ligand, remain understudied in drug discovery and development. Orphan neuropeptides and oGPCRs are abundantly expressed within the brain and represent an unprecedented opportunity to address brain function and may hold potential as novel treatments for disease. Here, we describe the current literature regarding orphaned neuropeptides and oGPCRs implicated in AUD. Specifically, in this review, we focus on the orphaned neuropeptide cocaine- and amphetamine-regulated transcript (CART), and several oGPCRs that have been directly implicated in AUD (GPR6, GPR26, GPR88, GPR139, GPR158) and discuss their potential and pitfalls as novel treatments, and progress in identifying their cognate receptors or ligands.